Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 2/20 | 0.36 |
| ▸ | NOS3 | P29474 | 1/20 | 0.36 |
| ▸ | NOS2 | P35228 | 1/20 | 0.36 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.36 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.35 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.34 |
| ▸ | PGD | P52209 | 1/20 | 0.34 |
| ▸ | BHMT | Q93088 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL330114 | 1.00 | LTA4H (0.36) | LTA4HNOS1NOS3NOS2SLC7A5 | |
| SCHEMBL375959 | 1.00 | LTA4H (0.36) | LTA4HNOS1NOS3NOS2SLC7A5 | |
| Water SCHEMBL30283282 | 0.98 | LTA4H (0.36) | LTA4HNOS1NOS3NOS2SLC7A5 | |
| Hydrochloric Acid SCHEMBL6700549 | 0.98 | LTA4H (0.36) | LTA4HNOS1NOS3NOS2SLC7A5 | |
| Hydrochloric Acid SCHEMBL6700554 | 0.98 | LTA4H (0.36) | LTA4HNOS1NOS3NOS2SLC7A5 | |
| Hydrochloric Acid SCHEMBL25276889 | 0.98 | LTA4H (0.36) | LTA4HNOS1NOS3NOS2SLC7A5 | |
| SCHEMBL28833837 | 0.98 | LTA4H (0.36) | LTA4HNOS1NOS3NOS2SLC7A5 | |
| Hydrochloric Acid SCHEMBL30947817 | 0.86 | KDM4E (0.38) | GRIK1PGDBHMTGABRR1LMNA | |
| SCHEMBL17732318 | 0.86 | PGD (0.37) | GRIK1PGDBHMTGABRR1LMNA | |
| SCHEMBL29720991 | 0.85 | DGAT1 (0.34) | NOS1NOS3NOS2SLC7A5GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240317780-A1 | RADIOPHARMACEUTICAL SOMATOSTATIN RECEPTOR LIGANDS AND PRECURSORS THEREOF | Technische Universität München (DE) | 2024-09-26 | — | — | US | disclosed |
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| US-20240115553-A1 | COMPOSITIONS AND METHODS FOR TREATING BRAIN INJURY | AZEVAN PHARMACEUTICALS, INC. (US) | 2024-04-11 | — | — | US | disclosed |
| US-20240011979-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS INC. (KR) | 2024-01-11 | — | — | US | disclosed |
| CN-117320759-A | Radiopharmaceutical somatostatin receptor ligands and precursors thereof | 慕尼黑工业大学 | 2023-12-29 | — | — | CN | disclosed |
| WO-2023075435-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | 주식회사 베르티스 | 2023-05-04 | — | — | WO | disclosed |
| US-20220283131-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS CO., LTD. (KR) | 2022-09-08 | — | — | US | disclosed |
| US-11319306-B2 | Compositions and methods for treating neurodegenerative diseases | AZEVAN PHARMACEUTICALS, INC. (US) | 2022-05-03 | — | — | US | disclosed |
| WO-2022050529-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | ㈜베르티스 | 2022-03-10 | — | — | WO | disclosed |
| EP-2414319-B1 | NICOTIANAMINE-DERIVED METALLOPHORE AND PROCESSES FOR PRODUCING SAME | COMMISSARIAT L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2015-07-01 | — | — | EP | disclosed |
| US-8563280-B2 | Nicotianamine-derived metallophore and processes for producing same | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2013-10-22 | — | — | US | disclosed |
| US-8563280-B2 | Nicotianamine-derived metallophore and processes for producing same | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2013-10-22 | — | — | US | disclosed |
| US-20120095262-A1 | Nicotianamine-Derived Metallophore And Processes For Producing Same | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2012-04-19 | — | — | US | disclosed |
| US-20120095262-A1 | Nicotianamine-Derived Metallophore And Processes For Producing Same | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2012-04-19 | — | — | US | disclosed |
| WO-2010112697-A1 | NICOTIANAMINE-DERIVED METALLOPHORE AND PROCESSES FOR PRODUCING SAME | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2010-10-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120095262-A1 | Nicotianamine-Derived Metallophore And Processes For Producing Same | NIT2, NNMT, NQO1 | LTA4H 1044/4885NOS1 249/4885NOS3 561/4885 |
| US-20240115553-A1 | COMPOSITIONS AND METHODS FOR TREATING BRAIN INJURY | FABP7, PYGB, CHAT | LTA4H 927/4885NOS1 848/4885NOS3 185/4885 |
| US-11319306-B2 | Compositions and methods for treating neurodegenerative diseases | HTT, AVPR2, AVPR1B | LTA4H 1747/4885NOS1 1389/4885NOS3 1270/4885 |
| US-20240317780-A1 | RADIOPHARMACEUTICAL SOMATOSTATIN RECEPTOR LIGANDS AND PRECURSORS THEREOF | SSTR1, SSTR3, SSTR4 | LTA4H 4059/4885NOS1 2793/4885NOS3 3032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.